Response to the 2009 pandemic: Effect on influenza control in wealthy and poor countries

Vaccine

Volumn 29, Issue 38, 2011, Pages 6427-6431

  Monto, Arnold S ^a   Black, Steven ^b   Plotkin, Stanley A ^c   Orenstein, Walter A ^d  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

Developing countries; Influenza; International health regulations; Pandemic; Vaccine supply

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; AVIAN INFLUENZA; DEVELOPING COUNTRY; DISEASE SEVERITY; EUROPE; FATALITY; HUMAN; INDUSTRIALIZATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; NONHUMAN; NOTE; PANDEMIC; PRIORITY JOURNAL; SWINE INFLUENZA VIRUS; THREAT; WORLD HEALTH ORGANIZATION;

ANIMALS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; VACCINATION; WORLD HEALTH;

EID: 80051668051     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.113     Document Type: Note

References (33)

1. Pandemic influenza preparedness and response: a WHO guidance document 2009, World Health Organization, ISBN:978 02 4 154768 0.
2. Chan M. World now at the start of 2009 influenza pandemic 2009 June, WHO, [Accessed April 12, 2011 at http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/].
3. Dominguez-Cherit G., Lapinsky S.E., Macias A.E., et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009, 302(17):1880-1887.
4. Transcript of statement by Margaret Chan, Director-General of the World Health Organization 2009 April, WHO, [Accessed April 12, 2011 at http://www.who.int/mediacentre/influenzaAH1N1_presstranscript_20090611.pdf].
5. Joint statement by the UN Secretary-General and the WHO Director-General 2009 September, WHO, [Accessed April 12, 2011 at http://www.who.int/mediacentre/news/statements/2009/h1n1_support_20090924/en/].
6. Report to the President on U.S. preparations for 2009-H1N1 Influenza 2009 August, PCAST, [Accessed April 12, 2011 at http://www.whitehouse.gov/administration/eop/ostp/pcast/docsreports].
7. Jhung M.A., Swerdlow D., Olsen S.J., et al. Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin Infect Dis 2011, 52:S13-S26.
8. Jamieson D.J., Honein M.A., Rasmus S.A., et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009, 374:451-458.
9. The handling of the H1N1 pandemic: more transparency needed. Parliamentary Assembly [Accessed April 12, 2011 at ]. http://www.assembly.coe.int/CommitteeDocs/2010/20100604_H1N1pandemic_e.pdf.
10. Bellemare J. Canada to bridge Mexico's H1N1 flu vaccine requirements 2010 January, Public Health Agency of Canada, [Accessed April 12, 2011 at http://www.phac-aspc.gc.ca/media/nr-rp/2010/2010_0106-eng.php].
11. Yamada T. Poverty, wealth, and access to pandemic influenza vaccines. N Engl J Med 2009, 361:1129-1131.
12. Lee N., Hui D., Wu A., et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003, 348:1986-1994.
13. Li K.S., Guan Y., Wang J., et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004, 430:209-213.
14. Hien T.T., de Jong M., Farrar J. Avian influenza-a challenge to global health care structures. N Engl J Med 2004, 351:2363-2365.
15. Kilpatrick A.M., Chmura A.A., Gibbons D.W., et al. Predicting the spread of H5N1 avian influenza. Proc Natl Acad Sci 2006, 103:19368-19373.
16. Monto A.S. Vaccines and antiviral drugs in pandemic preparedness. Emerg Infect Dis 2006, 12:55-60.
17. Stephenson I., Bugarini R., Nicholson K.G., et al. Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy. J Infect Dis 2005, 191:1210-1215.
18. Leroux-Roels I., Borkowski A., Vanwolleghem T., et al. Antigen sparing and cross-reactive immunity with an adjuvanted H5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 2007, 370:580-589.
19. Jennings L.C., Monto A.S., Chan P.K.S., et al. Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. Lancet Infect Dis 2008, 8:650-658.
20. International Health Regulations 2005, WHO, [accessed April 12, 2011 at http://www.who.int/ihr/en/].
21. Perez-Padilla R., de la Rosa-Zamboni D., Ponce de Leon S., et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009, 361:680-689.
22. List of Members of, and Advisor to, the International Health Regulations (2005) Emergency Committee concerning Influenza Pandemic (H1N1) 2009 2010 October, WHO, [Accessed April 12, 2011 at http://www.who.int/ihr/emerg_comm_members_2009/en/].
23. What is swine flu? BBC Health 2010 November, [Accessed April 12, 2011 at http://www.bbc.co.uk/health/physical_health/conditions/swineflumulti1.shtml].
24. Kumar A., Zarychanski R., Pinto R., et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009, 302:1872-1879.
25. Strategic Advisory Group of Experts on Immunization-report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic, 7 July 2009. Wkly Epidemiol Rec 2009, 84:301-308.
26. Center for Disease Control and Prevention Intensive-care patients with 2009 influenza a (H1N1) virus infection-Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009, 58:749-752.
27. Shrestha A.A., Swerdlow D.L., Borse R.H., et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis 2011, 52:S75-S82.
28. Thompson W.W., Shay D.K., Weintraub E., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
29. Viboud C., Miller M., Olson D., et al. Preliminary estimates of mortality and years of life lost associated with the 2009 A/H1N1 pandemic in the US and comparison with past influenza seasons. PLoS Curr 2010, 2(March):RRN1153. 10.1371/currents.RRN1153.
30. Implementation of the International Health Regulations (2005): report of the Review Committee on the Functioning of the International Health Regulations (2005) and on Pandemic Influenza (H1N1) 2009, [Accessed June 27, 2011 at http://apps.who.int/gb/ebwha/pdf_files/WHA64/A64_10-en.pdf].
31. CDC's Advisory Committee on Immunization Practices (ACIP) Recommends universal annual influenza vaccination 2010 February, Centers for Disease Control and Prevention, [Accessed April 12, 2011 at http://www.cdc.gov/media/pressrel/2010/r100224.htm].
32. Kieny M.P., Costa A., Hombach J., et al. A global pandemic influenza action plan. Vaccine 2006, 24:6367-6370.
33. Brooks A., Goswami D., Rahman M., et al. Influenza is a major contributor to childhood pneumonia in a tropical developing country. Pediatr Infect Dis 2010, 29:216-221.